Plazumab

N/A

Report date: 2024/04/30 16:21:48

Base Information

Drug NamePlazumab
Drug Alias NameDIACC-1010
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionAnti-Phospholipase A2
TargetsPhospholipase A2
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEvexta Bio SA
China Registration ClassN/A

Develop Information

Active CompaniesEvexta Bio SA
Inactive CompaniesN/A
Active IndicationsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A